Hadar Marcus
Papers
2
Total Citations
29
H-Index
2
About
Hadar Marcus is a leading researcher in the field of biodefense and neurotoxinology, with a primary focus on botulinum neurotoxins (BoNT)—among the most lethal substances known to humanity. Her work centers on developing advanced antibody-based countermeasures against botulism, a potentially fatal paralytic disease caused by BoNT serotypes A, B, and E. Marcus’s major contributions include pioneering the evaluation of synergistic neutralizing effects of oligoclonal antibody preparations, demonstrating that combining multiple monoclonal antibodies can enhance neutralization potency against diverse BoNT serotypes. Her research, notably her 2014 paper on this topic (27 citations), has significantly advanced the design of more effective therapeutic and diagnostic tools. Additionally, she developed a novel trivalent immunization protocol coupled with a simultaneous differential robotic screen to generate serotype-specific monoclonal antibodies, streamlining the production of targeted immunotherapeutics. Marcus’s work is critical for improving preparedness against botulism outbreaks and bioterrorism threats, offering a path toward safer, more reliable treatments than traditional polyclonal antibodies. Her innovative approaches continue to shape the landscape of antitoxin development and neurotoxin research.
Research Focus
Key Achievements
Top Papers
- 1
- 2